ProductLife Group Expands With HERAX Acquisition in Life Sciences

In a significant move within the life sciences consulting sector, ProductLife Group (PLG) has acquired Danish firm HERAX Life Science. This acquisition, announced on February 24, 2025, represents a key enhancement in PLG’s capabilities across R&D business and IT consultancy. The union is set to expand PLG’s offerings in digitising R&D activities and optimising clinical development processes, potentially transforming industry standards in safety and compliance.

Founded in Copenhagen in 2009, HERAX Life Science has established itself as a niche consultancy, specialising in bespoke business and IT solutions for the life sciences sector. Through this acquisition, PLG, already a prominent player in regulatory and digital transformation services, aims to integrate HERAX’s specialised approach to amplify its impact on global life sciences enterprises. The acquisition aligns with PLG’s strategic goal of strengthening its foothold in the Nordics and reinforces its existing regional operations following the earlier acquisition of Pharma IT in 2022.

This strategic alliance combines PLG’s global reach with HERAX’s local expertise, promising improved support for both local and international clients. Allan Bech Thomsen, CEO of HERAX, expressed optimism about the partnership, emphasising its potential to enhance client service in GxP regulated areas. Meanwhile, PLG’s CEO, Xavier Duburcq, highlighted the combined team’s expertise in critical R&D areas, promising tailored solutions to industry challenges.

In conclusion, this acquisition positions PLG as a formidable entity in the life sciences consulting arena, dedicated to driving digital transformation, regulatory compliance, and international expansion.

For the latest updates and in-depth insights into the world of Life Science, including breakthrough treatments, industry trends, and regulatory news, contact James Higgins today!